Final presentation given by Ileana Lulic and Ivor Kovic at the end of Scientific research in gastro-intestinal & liver diseases
Sunday, July 8 - Friday, August 3, 2007
Amsterdam, Academisch Medisch Centrum
This document discusses cytogenetic abnormalities in myeloma detected by fluorescence in situ hybridization (FISH). It summarizes the experience at Hong Kong Sanatorium & Hospital using FISH to detect abnormalities including t(4;14), t(14;16), del(17p), and 1q gain. Key findings from 105 cases are reported, such as frequencies of 16% for t(4;14), 3% for t(14;16), 6% for del(17p), and 42% for 1q gain. Comparative data from other studies on frequencies of FISH abnormalities are also presented. Examples are provided showing how FISH can help distinguish between myeloma and related disorders in difficult cases.
This document summarizes the results of a Spanish registry of 233 percutaneous coronary interventions for chronic total occlusions caused by in-stent restenosis. The technical success rate was 77.2%, with lower success in the circumflex artery. Procedural complications occurred in 14.7% of cases. At a median follow-up of 20 months, the rates of major adverse cardiac events and mortality were similar between the successful and failed PCI groups, though the successful group showed trends towards lower events and mortality.
1. Minimal residual disease (MRD) measured during treatment for acute lymphoblastic leukemia has been shown to strongly correlate with patient outcomes and survival rates.
2. MRD can identify low-risk and high-risk patient groups more accurately than morphological assessments alone. Several studies demonstrate integrating MRD into risk-adapted clinical trial designs.
3. MRD may serve as a surrogate endpoint for assessing response to new investigational agents in relapsed ALL, to help prioritize agents for further study and potential accelerated approval.
1) The risk of contrast-induced acute kidney injury (CI-AKI) was assessed in a propensity score-matched cohort study.
2) The study found that use of RAAS blockade medications like ACE inhibitors and ARBs was associated with a 43% higher risk of CI-AKI.
3) Other independent risk factors for CI-AKI included chronic kidney disease, hemoglobin level <10 g/dL, albumin level <3.5 g/dL, higher contrast volume, and diuretic use.
The document appears to contain case summaries from various pathology reports. It includes cases of:
- Mucoepidermoid carcinoma of the breast
- Micropapillary invasive ductal carcinoma of the breast
- Chordoma of the skull
- Hepatocellular carcinoma of the liver
- Papillary thyroid carcinoma
- Endometrioid adenocarcinoma of the ovary associated with endometriosis
- Mucinous carcinoma developing in a background of intraductal papillary mucinous neoplasm of the pancreas
1) Acute poststreptococcal glomerulonephritis (APSGN) is caused by previous infection with Group A streptococcus and is characterized by acute onset of hematuria, edema, and hypertension.
2) Histologically, APSGN typically shows diffuse proliferative glomerulonephritis with neutrophil infiltration, C3 deposition along the glomerular capillaries, and subepithelial humps on electron microscopy.
3) The differential diagnosis of APSGN includes other causes of postinfectious glomerulonephritis, lupus nephritis, and IgA nephropathy. Distinguishing features include clinical presentation and serological
This document summarizes extrahepatic manifestations that can occur due to hepatitis C virus infection. Some of the most common manifestations mentioned include vasculitis, fatigue, arthralgia-myalgia, and sicca syndrome. The document discusses how HCV can affect multiple organ systems like the skin, nerves, blood cells, and kidneys. It also explores the pathogenesis of conditions like cryoglobulinemia and suggests immune-mediated mechanisms involving B cells, T cells, and cytokines may play a role in extrahepatic disease manifestations from HCV.
1. The document discusses common mistakes that can occur during upper gastrointestinal endoscopy and how to avoid them. It describes mistakes like missing Cameron ulcers, Dieulafoy lesions, eosinophilic esophagitis, long segment Barrett's esophagus, and confusion between portal hypertensive gastropathy and gastric antral vascular ectasia.
2. Key recommendations include paying close attention to the cardia region in patients with large hiatal hernias, performing urgent endoscopy in cases of new bleeding, asking patients to cough to induce bleeding from possible Dieulafoy lesions, taking multiple biopsies to diagnose eosinophilic esophagitis, and actively searching for the Z-line in cases
This document discusses cytogenetic abnormalities in myeloma detected by fluorescence in situ hybridization (FISH). It summarizes the experience at Hong Kong Sanatorium & Hospital using FISH to detect abnormalities including t(4;14), t(14;16), del(17p), and 1q gain. Key findings from 105 cases are reported, such as frequencies of 16% for t(4;14), 3% for t(14;16), 6% for del(17p), and 42% for 1q gain. Comparative data from other studies on frequencies of FISH abnormalities are also presented. Examples are provided showing how FISH can help distinguish between myeloma and related disorders in difficult cases.
This document summarizes the results of a Spanish registry of 233 percutaneous coronary interventions for chronic total occlusions caused by in-stent restenosis. The technical success rate was 77.2%, with lower success in the circumflex artery. Procedural complications occurred in 14.7% of cases. At a median follow-up of 20 months, the rates of major adverse cardiac events and mortality were similar between the successful and failed PCI groups, though the successful group showed trends towards lower events and mortality.
1. Minimal residual disease (MRD) measured during treatment for acute lymphoblastic leukemia has been shown to strongly correlate with patient outcomes and survival rates.
2. MRD can identify low-risk and high-risk patient groups more accurately than morphological assessments alone. Several studies demonstrate integrating MRD into risk-adapted clinical trial designs.
3. MRD may serve as a surrogate endpoint for assessing response to new investigational agents in relapsed ALL, to help prioritize agents for further study and potential accelerated approval.
1) The risk of contrast-induced acute kidney injury (CI-AKI) was assessed in a propensity score-matched cohort study.
2) The study found that use of RAAS blockade medications like ACE inhibitors and ARBs was associated with a 43% higher risk of CI-AKI.
3) Other independent risk factors for CI-AKI included chronic kidney disease, hemoglobin level <10 g/dL, albumin level <3.5 g/dL, higher contrast volume, and diuretic use.
The document appears to contain case summaries from various pathology reports. It includes cases of:
- Mucoepidermoid carcinoma of the breast
- Micropapillary invasive ductal carcinoma of the breast
- Chordoma of the skull
- Hepatocellular carcinoma of the liver
- Papillary thyroid carcinoma
- Endometrioid adenocarcinoma of the ovary associated with endometriosis
- Mucinous carcinoma developing in a background of intraductal papillary mucinous neoplasm of the pancreas
1) Acute poststreptococcal glomerulonephritis (APSGN) is caused by previous infection with Group A streptococcus and is characterized by acute onset of hematuria, edema, and hypertension.
2) Histologically, APSGN typically shows diffuse proliferative glomerulonephritis with neutrophil infiltration, C3 deposition along the glomerular capillaries, and subepithelial humps on electron microscopy.
3) The differential diagnosis of APSGN includes other causes of postinfectious glomerulonephritis, lupus nephritis, and IgA nephropathy. Distinguishing features include clinical presentation and serological
This document summarizes extrahepatic manifestations that can occur due to hepatitis C virus infection. Some of the most common manifestations mentioned include vasculitis, fatigue, arthralgia-myalgia, and sicca syndrome. The document discusses how HCV can affect multiple organ systems like the skin, nerves, blood cells, and kidneys. It also explores the pathogenesis of conditions like cryoglobulinemia and suggests immune-mediated mechanisms involving B cells, T cells, and cytokines may play a role in extrahepatic disease manifestations from HCV.
1. The document discusses common mistakes that can occur during upper gastrointestinal endoscopy and how to avoid them. It describes mistakes like missing Cameron ulcers, Dieulafoy lesions, eosinophilic esophagitis, long segment Barrett's esophagus, and confusion between portal hypertensive gastropathy and gastric antral vascular ectasia.
2. Key recommendations include paying close attention to the cardia region in patients with large hiatal hernias, performing urgent endoscopy in cases of new bleeding, asking patients to cough to induce bleeding from possible Dieulafoy lesions, taking multiple biopsies to diagnose eosinophilic esophagitis, and actively searching for the Z-line in cases
The document discusses updates in colorectal cancer screening, including different pathways and precursors of colorectal cancer, optimal terminology for classifying serrated lesions, variability in detection rates among endoscopists, importance of adequate bowel preparation and withdrawal technique, and technical solutions such as chromoendoscopy to help improve adenoma detection.
Fish - Fluorescence In Situ HybridizationLingasamyC
This document provides an overview of fluorescence in situ hybridization (FISH). FISH is a cytogenetic technique used to detect and localize specific DNA sequences on chromosomes. The document discusses the history of FISH, basic methodology which involves using fluorescent probes and microscopy, sample and probe requirements, clinical applications for detecting cancers and genetic abnormalities, and factors that can affect FISH results. In summary, FISH is an important technique for detecting chromosomal abnormalities, it has applications in cancer diagnosis and genetic testing, and accurate performance requires consideration of many technical factors.
Fish - Fluorescence In Situ HybridizationSureshK143
This document provides an overview of fluorescence in situ hybridization (FISH). FISH is a cytogenetic technique used to detect and localize specific DNA sequences on chromosomes. The document discusses the history of FISH, basic methodology, sample and probe requirements, clinical applications for detecting various cancers and genetic abnormalities, factors affecting FISH results, and recent advances like spectral karyotyping. In summary, FISH allows rapid detection of genetic changes through fluorescent labeling and hybridization of DNA probes to complementary sequences on chromosomes.
This document provides an overview of prostate cancer, including who is affected, risk factors, detection methods like PSA testing and biopsy, staging using the Gleason score and TNM system, and treatment options like surgery, radiation therapy, active surveillance, and androgen blockade. It discusses outcomes for different treatments and challenges in managing prostate cancer recurrence after initial therapy.
This document provides information on paediatric oncology and various childhood cancers. It discusses that benign tumors are more common than malignant tumors in children, but cancer is a leading cause of death after accidents. The most common malignant tumors in children arise from hematopoietic, nervous and soft tissues. It then describes several specific childhood cancers like acute lymphoblastic leukemia, Wilms tumor, neuroblastoma, Hodgkin's lymphoma, and non-Hodgkin lymphoma. For each cancer, it discusses clinical features, diagnostic evaluation, classification, treatment and prognosis.
This document discusses individual prognosis and predictive biomarkers in breast cancer. It covers classical prognostic factors like age, grade, histological subtypes, hormone receptor status, Ki67, and more. It also discusses intrinsic subtypes defined by gene expression profiling that can be translated to immunohistochemistry. Several gene expression signatures are mentioned, including MammaPrint, OncotypeDX, EndoPredict, and Prosigna, which provide prognostic and predictive information. Accurate pathology testing is essential for treatment decisions, and gene signatures may increase confidence, though some cases will still be challenging.
This document discusses the changing landscape of cancer of unknown primary (CUP) over four decades from 1976 to the present. It describes the evolution from recognition of favorable prognostic subsets in 1976-1986, to improved diagnostic techniques in 1986-1996, to empiric chemotherapy in 1996-2006, and currently to improved pathologic and genetic diagnostic technologies and better outcomes for many CUP patients from 2006 onward. The document provides details on histologic classification, clinicopathologic entities, diagnostic approaches including imaging, histopathology, immunohistochemistry, and molecular analysis, as well as discussion of favorable and unfavorable prognostic subsets and treatment approaches.
This document provides information on abnormal Pap smear results and cervical cancer screening. It discusses the prevalence and mortality rates of cervical cancer globally. It then covers the Pap test procedure and interpretation, abnormal result categories like ASC-US, LSIL, HSIL, and AGC. Management guidelines are presented for different abnormal results, including initial testing and follow up. Special populations like adolescents and pregnant women are also addressed.
This document discusses the management of Barrett's esophagus, which is the development of intestinal metaplasia in the esophagus. It presents the stages of progression from non-dysplastic Barrett's to low-grade dysplasia to high-grade dysplasia and eventually cancer. It reviews the risks of progression and recommends surveillance strategies. It also discusses endoscopic treatment options like endoscopic mucosal resection and radiofrequency ablation to remove dysplastic tissue, with the goal of complete eradication of Barrett's. Acid suppression with proton pump inhibitors is an essential part of co-therapy.
Current Diagnosis And Management Of Prostate Cancerfondas vakalis
1) Prostate cancer risk factors include increasing age, family history, and lifestyle factors like smoking and high fat diets.
2) Screening methods include digital rectal exam and PSA testing, though screening recommendations vary.
3) Treatment options depend on cancer severity and include watchful waiting, surgery, radiation, hormone therapy, and cryotherapy. Long-term side effects can include incontinence and impotence.
FDG-PET and PET/CT are useful tools for detecting unknown primary tumors in patients presenting with cervical lymph node metastases. A review of studies found that FDG-PET detected the primary tumor in 24.5-51% of cases where conventional workup was negative. Identifying the primary tumor allows for targeted therapy and improves prognosis by avoiding wide-field irradiation. One study noted FDG-PET findings changed treatment management in 25% of cases with unknown primary tumors.